T. V. Lukina et al. / Tetrahedron Letters 46 (2005) 1205–1207
1207
67.88 (C-3), 124.66, 130.95, 132.07, 133.74, 136.71, 147.42
(carbons of Ns), 126.88, 128.58, 129.47, 133.35 (Ph).
6. Crystallographic data for compound 6a: C11H13N5O4S,
Mr = 311.32, monoclinic space group P2(1)/n, a =
can be obtained from halides 7 by exposure to various
bases) were obtained as side products along with the tar-
get compounds 7.
˚
8.4690(17), b = 8.4690(17), c = 9.806(2) A, a = 90, b =
Thus, quite stable triazolopiperazines 6 can be obtained
by intramolecular [2+3] cycloaddition of the azide
group in 5 to the C@C bond. The reaction proceeds
stereoselectively in acceptable yields. We showed that
the halogenomethyl derivatives 7 as precursors for the
hydrogenated pyrazino[1,2-a]pyrazines can be obtained
by a previously unknown reaction of triazolines 6 with
alkyl and acyl halides.
3
˚
110.56(3), c = 90°, V = 1339.3(5) A , Z = 4, T = 293(2) K,
F(000) = 648, l = 0.267 mmꢀ1, hmax = 27.79°, 2588 reflec-
tions measured and 2362 unique (Rint = 0.0171) reflections,
full matrix least-squares refinement on F2, R1
(obsd) = 0.0930, and wR2 (all data) = 0.1090. Crystallo-
graphic data for compound 6d: C18H19N5O4S, Mr = 401.44,
monoclinic space group P2(1)/n, a = 8.026(2), b =
˚
11.449(4), c = 10.376(4) A a = 90, b = 97.08(2), c = 90°,
V = 946.2(5) A , Z = 2, T = 293(2) K, F(000) = 420,
3
˚
l = 0.207 mmꢀ1. hmax = 29.97°, 3066 reflections measured
and 2856 unique (Rint = 0.0171) reflections, full matrix
least-squares refinement on F2,R1 (obsd) = 0.0932, and
wR2 (all data) = 0.1804. Supplementary data in the
form of CIFs have been deposited with the Cambridge
Crystallographic Data Centre (CCDC 249283 and 249284).
Copies of the data can be obtained, free of charge, on
application to CCDC, 12 Union Road, Cambridge CB2
1EZ, UK [fax: +44(0) 1223 336033 or e-mail:
deposit@ccdc.cam.ac.uk].
References and notes
1. (a) Kim, H.-O.; Nakanishi, H.; Lee, M. S.; Kahn, M. Org.
Lett. 2000, 2, 301–302; (b) Golebiowski, A.; Klopfenstein,
S. R.; Chen, J. J.; Shao, X. Tetrahedron Lett. 2000, 41,
4841–4844; (c) Golebiowski, A.; Klopfenstein, S. R.; Shao,
X.; Chen, J. J.; Colson, A.-O.; Grieb, A. L.; Russell, A. F.
Org. Lett. 2000, 2, 2615–2617.
2. (a) Gubert, S.; Braojos, C.; Sacristan, A.; Ortiz, J. A.
Synthesis 1991, 318–320; (b) Sturm, P. A.; Cory, M.; Henry,
D. W.; McCall, J. W.; Ziegler, J. B. J. Med. Chem. 1977, 20,
1327–1333.
7. If dissolved in MeOH, the triazolines 6 transform within 3–
4 h into complicated mixtures, from which compounds 7
(X = OMe, R2 = H) can be isolated sometimes in ꢁ15%
yield.
3. (a) Keshava Murthy, K. S.; Hassner, A. Tetrahedron Lett.
1987, 28, 97–100; (b) Hassner, A.; Amarasekara, A. S.;
Andisik, D. J. Org. Chem. 1988, 53, 27–30; (c) Rai, K. M.
L.; Hassner, A. Heterocycles 1990, 30, 817–830.
8. Iodomethylates 7 (R2 = Me; X = I) were isolated when an
excess of methyl iodide was used. In other cases, no
quaternization was observed.
4. (a) Bowman, W. R.; Coghlan, D. R. Tetrahedron 1997, 53,
15787–15798; (b) Skerlj, R. T.; Nan, S.; Zhou, Y.; Bridger,
G. J. Tetrahedron Lett. 2002, 43, 7569–7572.
9. Preparation of 7da (R2 = Bn; X = Br): A solution of benzyl
bromide (0.2 g, 1.1 mmol) in acetonitrile (10 mL) was
added dropwise to a solution of 6d (0.5 g, 1 mmol) in
acetonitrile (7 mL) under argon. After standing overnight,
the acetonitrile was evaporated, and the residue was
purified by chromatography on silica gel (hexane/dichloro-
methane in gradient 95:5 to 0:100 then dichloromethane/
chloroform in gradient 95:5 to 0:100) to afford 7da (0.6 g,
89%). 1H NMR (CDCl3, 400 MHz): d 2.15 (1H, dd,
J = 11.8 Hz, J = 3.6 Hz, 6-HA), 2.54 (1H, m, 2-H), 2.69
(1H, dd, J = 11.8 Hz, J = 1.8 Hz, 6-HB), 2.87 (1H, dd,
J = 12.9 Hz, J = 5.2 Hz, 5-CH2Ph), 2.90 (1H,
d, J = 12.5 Hz, 1-CH2Ph), 3.10 (1H, dd, J = 12.9 Hz,
J = 9.4 Hz, 5-CH2Ph), 3.54 (1H, m, 3-HA), 3.56 (1H, m,
2-CH2Br), 3.76 (1H, m, 2-CH2Br), 3.80 (1H, m, 3-HB), 3.94
(1H, m, 5-H), 4.16 (1H, d, J = 12.5 Hz, 1-CH2Ph), 6.79–
6.82 and 6.97–7.00 (2H and 3H, m, 1-CH2Ph), 7.30–7.40
(5H, m, 5-CH2Ph), 7.60–7.65 and 7.88–7.91 (3H and 1H, m,
4-Ns). 13C NMR (CDCl3, 100 MHz) d 32.85 (2-CH2Br),
36.04 (5-CH2Ph), 45.27 (C-3), 52.16 (C-6), 56.40 (C-5),
56.87 (1-CH2Ph), 59.23 (C-2), 124.41, 130.91, 131.86,
133.36, 133.77, 147.54 (carbons of Ns), 126.24, 128.36,
129.24, 137.99 (1-CH2Ph), 127.39, 128.20, 129.59, 137.67
(5-CH2Ph).
5. Typical procedure for 6b: Azide 4d (3.0 g, 8 mmol) was
dissolved in acetonitrile (50 mL) and K2CO3 (2.3 g,
16 mmol), allyl bromide (1.4 g, 10 mmol) and then 18-
crown-6 (0.4 g, 2 mmol) were added to the mixture, which
was then stirred for 3 h at room temperature. The solvent
was evaporated, and the residue was purified by chroma-
tography (alumina, hexane/dichloromethane 1:1). Com-
pound 5d was obtained and kept as a solution in
acetonitrile (200 mL) until complete cyclization to triazo-
line 6d, which was crystallized from hexane/ethyl acetate
1
mixture (2:1) to afford 6d (1.1 g, 34%). H NMR (CDCl3,
400 MHz): d 2.73 (1H, dd, J = 13.3 Hz, J = 5.6 Hz, 6-
CH2Ph), 2.83 (1H, dd, J = 13.3 Hz, J = 9.6 Hz, 6-CH2Ph),
3.05 (1H, dd, J = 14.1 Hz, J = 11.6 Hz, 4Hax), 3.52 (1H, dd,
J = 14.1 Hz, J = 5.0 Hz, 4-Heq), 3.65 (1H, m, 7-Hax), 3.77
(1H, m, 3a-H), 4.01 (1H, dd, J = 16.1 Hz, J = 9.8 Hz,
3-HA), 4.08 (1H, m, 6-H), 4.17 (1H, dd, J = 16.1 Hz,
J = 3.2 Hz, 3-HB), 4.25 (1H, d, J = 14.4 Hz, 7-Heq), 7.10–
7.22 (5H, m, 6-CH2Ph), 7.60–7.70 and 7.92–7.94 (3H and
1H, m, 5-Ns). 13C NMR (CDCl3, 100 MHz) d 35.48 (6-
CH2Ph), 40.81 (C-4), 46.42 (C-7), 52.44 (C-3a), 56.45 (C-6),